Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable Breast Cancer

The standard method for localizing non-palpable breast cancer is currently preoperative wire-guided localization, its positive margin rate still remains around 20-50%. This study aims to compare the accuracy and efficacy of wire vs. combined breast tissue markers in localizing non-palpable breast cancer.

Trial Details

NCT ID
NCT05797454
Phase
NA
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Wire-guided localization and marker clip localization
  • Wire-guided localization
Locations (sample)
  • Guangzhou, Guangdong, China|23.11667,113.25

Key Eligibility Criteria

  • female patients, age≥18 year
  • A score of ≥ 2 on the Eastern Cooperative Oncology Group scale
  • Patients pathologically diagnosed with untreated breast cancer by core-needle biopsy, with histologically confirmed non-palpable in situ cancer, in…
  • Patients are willing to undergo breast conserving surgery and have no contraindications to breast conserving surgery.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →